Metraipolis › archive › dc_7444bd44acd8

Switching Design for Assessment of Interchangeability in Biosimilar Studies — Europe PMC PMID:41754929

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41754929
DOI
10.3390/pharmaceutics18020187
License (as archived)
solo-consultazione
Archived
2026-11-06T09:31:31.277Z
SHA-256 of the archived text
f60b474d3a11a871280915700304f4134e1fe187921de453cae7eb7c5a11e931
Stable URL of this page
https://metraipolis.com/documento/dc_7444bd44acd8

How to cite

Switching Design for Assessment of Interchangeability in Biosimilar Studies — Europe PMC PMID:41754929 — Europe PMC (en), https://europepmc.org/article/MED/41754929 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7444bd44acd8 (Metraipolis archive dc_7444bd44acd8, sha256 f60b474d3a11a871280915700304f4134e1fe187921de453cae7eb7c5a11e931)
BibTeX
@misc{dc7444bd44acd8,
  title = {Switching Design for Assessment of Interchangeability in Biosimilar Studies — Europe PMC PMID:41754929},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754929},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7444bd44acd8; sha256 f60b474d3a11a871280915700304f4134e1fe187921de453cae7eb7c5a11e931},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754929. Agents can read the archived copy with the MCP tool read_document.